Possible adverse effects of immunotherapy in non-small cell lung cancer; treatment and follow-up of three cases

Possible adverse effects of immunotherapy in non-small cell lung cancer; treatment and follow-up of three cases

In the past decade novel agents are on the market for non-small cell lung cancer adenocarcinoma based on pharmacogenomics. The epidermal growth factor receptor mutation, anaplastic lymphoma kinase and programmed death-ligand 1 investigation is necessary in the everyday clinical practice for the onco...

Full description

Bibliographic Details
Main Authors: Paul Zarogoulidis, Panos Chinelis, Anastasia Athanasiadou, Theodora Tsiouda, Georgia Trakada, Anastasios Kallianos, Lemonia Veletza, Dimitris Hatzibougias, Electra Mihalopoulou, Eirini Goupou, Christoforos Kosmidis, Chrysanthi Sardeli, Haidong Huang, Wolfgang Hohenforst-Schmidt
Format: Article
Language:English
Published: Elsevier 2017-01-01
Series:Respiratory Medicine Case Reports
Subjects:
NSCLC
Immunotherapy
Adenocarcinoma
Nivolumab
Colitis
Pneumonitis
Pericarditis
Online Access:http://www.sciencedirect.com/science/article/pii/S2213007117302265

Internet

http://www.sciencedirect.com/science/article/pii/S2213007117302265

Similar Items